Metastasizing lung carcinomas in Hann: Wistar rats

Area of Science:

• Oncology
• Carcinogenesis
• Experimental Pathology

Background:

• Lung carcinomas are a leading cause of cancer-related deaths globally.
• Understanding the mechanisms of lung cancer metastasis is crucial for developing effective treatments.
• Existing animal models may not fully recapitulate the complexity of human lung cancer progression and metastasis.

Purpose of the Study:

• To investigate the efficacy of dipentylnitrosamine (DPNA) in inducing metastasizing lung carcinomas in rats.
• To characterize the incidence and metastatic patterns of DPNA-induced lung tumors.
• To evaluate the suitability of this model for studying human lung cancer metastasis.

Main Methods:

• Hann:Wistar rats were administered 25 weekly subcutaneous injections of DPNA at varying doses (0, 62.5, 125, 250 mg/kg).
• Tumor incidence, including primary lung carcinomas, and the frequency and sites of metastases were meticulously recorded.
• Histopathological analysis was performed to confirm tumor type and metastatic spread.

Main Results:

• DPNA induced lung carcinomas with high incidence in a dose-dependent manner, particularly in male rats.
• Metastases were observed in various organs, including lymph nodes, adrenal glands, kidneys, pancreas, bones, heart, mesentery, CNS, uterus, and ovaries.
• The metastatic pattern observed in rats showed significant similarity to patterns seen in human lung cancer cases.

Conclusions:

• Subcutaneous DPNA administration is a viable method for inducing metastasizing lung carcinomas in experimental animals.
• The observed metastatic profile closely resembles that of human lung cancer, validating its use as a preclinical model.
• This DPNA-induced rat model holds promise for advancing research into the biology and treatment of metastasizing lung carcinomas.